Mattias Westman

Mattias Westman is co-founder of Prosperity Capital Management (PCM), founded in 1996. He is currently based in Milan, Italy.

Previously, Mattias has served as a board member for corporations including Immunometrix, a company focused on non-invasive delivery of large molecules through the skin via patch, which was subsequently sold to CareDx (NASDAQ: CDNA). He also served on the board of Lineage Biosciences, a biotech researching cell-based therapy for a variety of conditions, which was sold to AbCellera (NASDAQ: ABCL). Mattias currently sits on the board of a biotech utilizing epigenomics for early stage, non-invasive cancer screenings – Bluestar Genomics. He also played an active role at a Swedish investment bank, HQ Bank. Prior to founding PCM, Mattias was director of Alfred Berg, a Swedish investment bank.

He holds a master’s degree from the Stockholm School of Economics.